Certified by Founder Lodge
Arthrosi Therapeutics, Inc.
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $153,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Arthrosi Therapeutics is a leading clinical-stage biotech company dedicated to advancing therapies for gout disease. Our proprietary oral drug candidate, AR882 which is currently in clinical
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 10 ,2025 | Series E | $153,000,000 |
HighLight Capital
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
AiPrise | $12,500,000 | (Oct 10, 2025)
Glue(US) | $20,000,000 | (Oct 10, 2025)
enurgen | $4,100,000 | (Oct 10, 2025)
Affinia Therapeutics | $40,000,000 | (Oct 10, 2025)
